Roche’s recent run of positive study results with breast cancer candidate giredestrant has come to an end with the failure of the persevERA trial.

Subscribe for Updates

Copyright 2025 dijee Intelligence Ltd.   dijee Intelligence Ltd. is a private limited company registered in England and Wales at Media House, Sopers Road, Cuffley, Hertfordshire, EN6 4RY, UK registration number 16808844